Wolverine Trading
ARRY

Wolverine Trading’s Array Biopharma Inc ARRY Stock Holding History

Wolverine Trading’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-84,000
Closed -$2.05M – 5517
2019
Q1 		$2.05M Buy
84,000
+52,600
+168% +$1.1M 0.01% 1519
2018
Q4 		$438K Sell
31,400
-13,000
-29% -$197K ﹤0.01% 2764
2018
Q3 		$675K Buy
44,400
+9,700
+28% +$149K ﹤0.01% 2761
2018
Q2 		$566K Hold
34,700
– – ﹤0.01% 2923
2018
Q1 		$566K Sell
34,700
-39,000
-53% -$625K ﹤0.01% 2923
2017
Q4 		$943K Sell
73,700
-22,700
-24% -$258K ﹤0.01% 2282
2017
Q3 		$1.19M Sell
96,400
-15,800
-14% -$147K ﹤0.01% 1747
2017
Q2 		$948K Buy
112,200
+14,400
+15% +$118K ﹤0.01% 1795
2017
Q1 		$888K Buy
97,800
+43,000
+78% +$458K ﹤0.01% 1820
2016
Q4 		$482K Buy
54,800
+1,200
+2% +$8.83K ﹤0.01% 2670
2016
Q3 		$334K Buy
53,600
+21,000
+64% +$81.2K ﹤0.01% 3083
2016
Q2 		$114K Buy
+32,600
New +$106K ﹤0.01% 3580

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wolverine Trading's ARRY Position: Q2 2019 in Review

Wolverine Trading sold out of Array Biopharma Inc (ARRY) in Q2 2019, closing a stake of 20,484 shares — an estimated $499K sold.

Wolverine Trading first reported a position in ARRY in Q3 2016 and held it in 9 quarters. The position peaked at $713K in Q3 2018. 318 funds tracked by Wall St. Rank hold ARRY as of Q2 2019.

  • Wolverine Trading reported no remaining Array Biopharma Inc position as of Q2 2019 after selling out during the quarter.
  • Wolverine Trading sold 20,484 Array Biopharma Inc shares in Q2 2019, an estimated $499K.
  • Wolverine Trading first reported a position in Array Biopharma Inc in Q3 2016 and held it in 9 quarters.
  • Wolverine Trading's Array Biopharma Inc position peaked at $713K in Q3 2018.
  • 318 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2019.

Based on Wolverine Trading's 13F filing for Q2 2019, filed 20 Aug 2019.